Medistim ASA (OSTO:MEDIO) 3-Year Revenue Growth Rate : 9.90% (As of Dec. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Medistim ASA 3-Year Revenue Growth Rate?

Medistim ASA's Revenue per Share for the three months ended in Dec. 2024 was kr8.25.

During the past 12 months, Medistim ASA's average Revenue per Share Growth Rate was 6.60% per year. During the past 3 years, the average Revenue per Share Growth Rate was 9.90% per year. During the past 5 years, the average Revenue per Share Growth Rate was 10.40% per year. During the past 10 years, the average Revenue per Share Growth Rate was 9.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Medistim ASA was 20.80% per year. The lowest was 5.40% per year. And the median was 10.65% per year.

Competitive Comparison of Medistim ASA's 3-Year Revenue Growth Rate

For the Medical Devices subindustry, Medistim ASA's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medistim ASA's 3-Year Revenue Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medistim ASA's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Medistim ASA's 3-Year Revenue Growth Rate falls into.

Save Embed

;

Save Embed

;

Medistim ASA 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Medistim ASA (OSTO:MEDIO) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Medistim ASA 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Medistim ASA's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Medistim ASA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medistim ASA (OSTO:MEDIO) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

MEDI:Norway 0OCD:UK MD1:Germany

Address

Okernveien 94, Oslo, NOR, 0579

Website

https://www.medistim.com

Medistim ASA is a medical device company. It is engaged in researching, developing, producing, distributing, and sales of medical equipment through its own business or participation in other companies, as well as related activities. The company's business is focused on cardiac and vascular surgery. The group operates in the USA, Europe, China, and the Rest of the World. The main divisions are sale of own products and sale of third-party products. Sale of own products has two business models, the capital model and the lease model. Third-party products segment sells medical devices from third party manufacturers in Norway, Sweden and Denmark. Key revenue is generated from Own Products segment.

Medistim ASA Headlines

No Headlines